Creating and Restoring Equal Access to Equivalent Samples Act (CREATES)

Leaders of the Senate and House Judiciary Committees, led by Sen. Patrick Leahy (D-VT), re-introduced legislation to combat anticompetitive practices that can block the market entry of lower-cost generic drugs.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply